Rapid dopamine transmission within the nucleus accumbens: Dramatic difference between morphine and oxycodone delivery

European Journal of Neuroscience

Volumn 40, Issue 7, 2014, Pages 3041-3054

  Vander Weele, Caitlin M ^a   Porter Stransky, Kirsten A ^a   Mabrouk, Omar S ^a   Lovic, Vedran ^a   Singer, Bryan F ^a   Kennedy, Robert T ^a   Aragona, Brandon J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Addiction; Motivation; Opioid; Reward

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; GLUTAMIC ACID; MONOAMINE; MORPHINE; NEUROTRANSMITTER; OXYCODONE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG ABUSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; MOTIVATION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; ANIMAL; DRUG EFFECTS; ELECTROCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; SECRETION (PROCESS); SPRAGUE DAWLEY RAT; SYNAPTIC TRANSMISSION;

ANIMALS; DOPAMINE; ELECTROCHEMISTRY; INFUSIONS, INTRAVENOUS; MALE; MICRODIALYSIS; MORPHINE; NUCLEUS ACCUMBENS; OXYCODONE; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION;

EID: 84908236380     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12709     Document Type: Article

References (81)

1. Andersson, J.L., Nomikos, G.G., Marcus, M., Hertel, P., Mathe, J.M. & Svensson, T.H. (1995) Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system. N.-S. Arch. Pharmacol., 352, 374-385.
2. A receptors in the endomorphin-1-, but not endomorphin-2-, induced dopamine efflux in the nucleus accumbens of freely moving rats. Eur. J. Pharmacol., 580, 87-94.
3. Aragona, B.J., Cleaveland, N.A., Stuber, G.D., Day, J.J., Carelli, R.M. & Wightman, R.M. (2008) Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events. J. Neurosci., 28, 8821-8831.
4. Aragona, B.J., Day, J.J., Roitman, M.F., Cleaveland, N.A., Wightman, R.M. & Carelli, R.M. (2009) Regional specificity in the real-time development of phasic dopamine transmission patterns during acquisition of a cue-cocaine association in rats. Eur. J. Neurosci., 30, 1889-1899.
5. Badrinarayan, A., Wescott, S.A., Vander Weele, C.M., Saunders, B.T., Couturier, B.E., Maren, S. & Aragona, B.J. (2012) Aversive stimuli differentially modulate real-time dopamine transmission dynamics within the nucleus accumbens core and shell. J. Neurosci., 32, 15779-15790.
6. Berridge, K.C. & Kringelbach, M.L. (2013) Neuroscience of affect: brain mechanisms of pleasure and displeasure. Curr. Opin. Neurobiol., 23, 294-303.
7. Boström, E., Simonsson, U.S. & Hammarlund-Udenaes, M. (2006) In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics. Drug Metab. Dispos., 34, 1624-1631.
8. Boström, E., Hammarlund-Udenaes, M. & Simonsson, U.S. (2008) Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine. Anesthesiology, 108, 495-505.
9. Cheer, J.F., Wassum, K.M., Sombers, L.A., Heien, M.L., Ariansen, J.L., Aragona, B.J., Phillips, P.E. & Wightman, R.M. (2007) Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J. Neurosci., 27, 791-795.
10. Chen, Z.R., Irvine, R.J., Somogyi, A.A. & Bochner, F. (1991) Mu receptor binding of some commonly used opioids and their metabolites. Life Sci., 48, 2165-2171.
11. Comer, S.D., Sullivan, M.A., Whittington, R.A., Vosburg, S.K. & Kowalczyk, W.J. (2008) Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology, 33 1179-1191.
12. Comer, S.D., Metz, V.E., Cooper, Z.D., Kowalczyk, W.J., Jones, J.D., Sullivan, M.A., Manubay, J.M., Vosburg, S.K., Smith, M.E., Peyser, D. & Saccone, P.A. (2013) Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts. Behav. Pharmacol., 24, 504-516.
13. Compton, W.M. & Volkow, N.D. (2006) Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depen., 81, 103-107.
14. Covey, D.P., Roitman, M.F. & Garris, P.A. (2014) Illicit dopamine transients: reconciling actions of abused drugs. Trends Neurosci., 37, 200-210.
15. Daberkow, D.P., Brown, H.D., Bunner, K.D., Kraniotis, S.A., Doellman, M.A., Ragozzino, M.E., Garris, P.A. & Roitman, M.F. (2013) Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals. J. Neurosci., 33, 452-463.
16. Dahchour, A., Quertemont, E. & De Witte, P. (1994) Acute ethanol increases taurine but neither glutamate nor GABA in the nucleus accumbens of male rats: a microdialysis study. Alcohol Alcoholism, 29, 485-487.
17. Davis, M.P., Varga, J., Dickerson, D., Walsh, D., LeGrand, S.B. & Lagman, R. (2003) Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy. Support. Care Cancer, 11, 84-92.
18. Di Chiara, G. & Imperato, A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA, 85, 5274-5278.
19. Fenu, S., Spina, L., Rivas, E., Longoni, R. & Di Chiara, G. (2006) Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression. Psychopharmacology, 187, 143-153.
20. Frank, S.T., Krumm, B. & Spanagel, R. (2008) Cocaine-induced dopamine overflow within the nucleus accumbens measured by in vivo microdialysis: a meta-analysis. Synapse, 62, 243-252.
21. Garris, P.A. & Wightman, R.M. (1994) Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J. Neurosci., 14, 442-450.
22. Gysling, K. & Wang, R.Y. (1983) Morphine-induced activation of A10 dopamine neurons in the rat. Brain Res., 277, 119-127.
23. Heien, M.L., Khan, A.S., Ariansen, J.L., Cheer, J.F., Phillips, P.E., Wassum, K.M. & Wightman, R.M. (2005) Real-time measurement of dopamine fluctuations after cocaine in the brain of behaving rats. Proc. Natl. Acad. Sci. USA, 102, 10023-10028.
24. Hyman, S.E., Malenka, R.C. & Nestler, E.J. (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci., 29, 565-598.
25. Ikemoto, S. (2007) Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res. Rev., 56, 27-78.
26. Ito, R., Dalley, J.W., Howes, S.R., Robbins, T.W. & Everitt, B.J. (2000) Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J. Neurosci., 20, 7489-7495.
27. Johnson, S.W. & North, R.A. (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci., 12, 483-488.
28. Kalso, E. (2007) How different is oxycodone from morphine? Pain, 132, 227-228.
29. Keithley, R.B. & Wightman, R.M. (2011) Assessing principal component regression prediction of neurochemicals detected with fast-scan cyclic voltammetry. ACS Chem. Neurosci., 2, 514-525.
30. Keithley, R.B., Heien, M.L. & Wightman, R.M. (2009) Multivariate concentration determination using principal component regression with residual analysis. TRAC-Trend. Anal. Chem., 28, 1127-1136.
31. Keithley, R.B., Carelli, R.M. & Wightman, R.M. (2010) Rank estimation and the multivariate analysis of in vivo fast-scan cyclic voltammetric data. Anal. Chem., 82, 5541-5551.
32. Kelley, A.E. (2004) Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci. Biobehav. R., 27, 765-776.
33. Lalovic, B., Kharasch, E., Hoffer, C., Risler, L., Liu-Chen, L.-Y. & Shen, D.D. (2006) Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites*. Clin. Pharmacol. Ther., 79, 461-479.
34. Lammel, S., Hetzel, A., Hackel, O., Jones, I., Liss, B. & Roeper, J. (2008) Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron, 57, 760-773.
35. Lammel, S., Ion, D.I., Roeper, J. & Malenka, R.C. (2011) Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron, 70, 855-862.
36. Lemberg, K.K., Heiskanen, T.E., Kontinen, V.K. & Kalso, E.A. (2009) Pharmacology of oxycodone: does it explain why oxycodone has become a bestselling strong opioid? Scand. J. Pain, 1, S18-S23.
37. 1 receptor agonists and non-selective opioid agonists in dog brain membranes. Brain Res., 1073, 290-296.
38. Lüscher, C. & Ungless, M.A. (2006) The mechanistic classification of addictive drugs. PLoS Med., 3, e437.
39. Matsui, A. & Williams, J.T. (2011) Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons. J. Neurosci., 31, 17729-17735.
40. Matthews, R.T. & German, D.C. (1984) Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience, 11, 617-625.
41. Mayer-Blackwell, B., Schlussman, S.D., Butelman, E.R., Ho, A., Ott, J., Kreek, M.J. & Zhang, Y. (2014) Self administration of oxycodone by adolescent and adult mice affects striatal neurotransmitter receptor gene expression. Neuroscience, 258, 280-291.
42. McCabe, S.E., West, B.T. & Boyd, C.J. (2013a) Leftover prescription opioids and nonmedical use among high school seniors: a multi-cohort national study. J. Adolescent Health, 52, 480-485.
43. McCabe, S.E., West, B.T. & Boyd, C.J. (2013b) Medical use, medical misuse, and nonmedical use of prescription opioids: results from a longitudinal study. Pain, 154, 708-713.
44. Melief, E.J., Miyatake, M., Bruchas, M.R. & Chavkin, C. (2010) Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling. Proc. Natl. Acad. Sci. USA, 107, 11608-11613.
45. Michael, D.J., Joseph, J.D., Kilpatrick, M.R., Travis, E.R. & Wightman, R.M. (1999) Improving data acquisition for fast-scan cyclic voltammetry. Anal. Chem., 71, 3941-3947.
46. Mierzejewski, P., Koros, E., Goldberg, S.R., Kostowski, W. & Stefanski, R. (2003) Intravenous self-administration of morphine and cocaine: a comparative study. Pol. J. Pharmacol., 55, 713-726.
47. Nestler, E.J. & Malenka, R.C. (2004) The addicted brain. Sci. Am., 290, 78-85.
48. Nielsen, C.K., Ross, F.B., Lotfipour, S., Saini, K.S., Edwards, S.R. & Smith, M.T. (2007) Oxycodone and morphine have distinctly different pharmacological profiles: radioligand binding and behavioural studies in two rat models of neuropathic pain. Pain, 132, 289-300.
49. Niikura, K., Ho, A., Kreek, M.J. & Zhang, Y. (2013) Oxycodone-induced conditioned place preference and sensitization of locomotor activity in adolescent and adult mice. Pharmacol. Biochem. Be., 110, 112-116.
50. Owesson-White, C.A., Roitman, M.F., Sombers, L.A., Belle, A.M., Keithley, R.B., Peele, J.L., Carelli, R.M. & Wightman, R.M. (2012) Sources contributing to the average extracellular concentration of dopamine in the nucleus accumbens. J. Neurochem., 121, 252-262.
51. Parker, L.A., Cyr, J.A., Santi, A.N. & Burton, P.D. (2002) The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine: evaluation by taste and place conditioning. Pharmacol. Biochem. Be., 72, 87-92.
52. Peckham, E.M. & Traynor, J.R. (2006) Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats. J. Pharmacol. Exp. Ther., 316, 1195-1201.
53. Phillips, P.E., Robinson, D.L., Stuber, G.D., Carelli, R.M. & Wightman, R.M. (2003a) Real-time measurements of phasic changes in extracellular dopamine concentration in freely moving rats by fast-scan cyclic voltammetry. Method. Mol. Med., 79, 443-464.
54. Phillips, P.E., Stuber, G.D., Heien, M.L., Wightman, R.M. & Carelli, R.M. (2003b) Subsecond dopamine release promotes cocaine seeking. Nature, 422, 614-618.
55. Pontieri, F.E., Tanda, G. & Di Chiara, G. (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc. Natl. Acad. Sci. USA, 92, 12304-12308.
56. Porter-Stransky, K.A., Wescott, S.A., Hershman, M., Badrinarayan, A., Vander Weele, C.M., Lovic, V. & Aragona, B.J. (2011) Cocaine must enter the brain to evoke unconditioned dopamine release within the nucleus accumbens shell. Neurosci. Lett., 504, 13-17.
57. Robinson, T.E. & Berridge, K.C. (2003) Addiction. Annu. Rev. Psychol., 54, 25-53.
58. Robinson, D.L., Venton, B.J., Heien, M.L. & Wightman, R.M. (2003) Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo. Clin. Chem., 49, 1763-1773.
59. Roitman, M.F., Stuber, G.D., Phillips, P.E., Wightman, R.M. & Carelli, R.M. (2004) Dopamine operates as a subsecond modulator of food seeking. J. Neurosci., 24, 1265-1271.
60. Rouge-Pont, F., Usiello, A., Benoit-Marand, M., Gonon, F., Piazza, P.V. & Borrelli, E. (2002) Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors. J. Neurosci., 22, 3293-3301.
61. B receptors in the endomorphin-1-, but not endomorphin-2-, induced dopamine efflux in the nucleus accumbens of freely moving rats. Eur. J. Pharmacol., 581, 276-282.
62. Shen, H.W., Scofield, M.D., Boger, H., Hensley, M. & Kalivas, P.W. (2014) Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse. J. Neurosci., 34, 5649-5657.
63. Sinkala, E., McCutcheon, J.E., Schuck, M.J., Schmidt, E., Roitman, M.F. & Eddington, D.T. (2012) Electrode calibration with a microfluidic flow cell for fast-scan cyclic voltammetry. Lab Chip, 12, 2403-2408.
64. Sombers, L.A., Beyene, M., Carelli, R.M. & Wightman, R.M. (2009) Synaptic overflow of dopamine in the nucleus accumbens arises from neuronal activity in the ventral tegmental area. J. Neurosci., 29, 1735-1742.
65. Song, P., Mabrouk, O.S., Hershey, N.D. & Kennedy, R.T. (2012) In vivo neurochemical monitoring using benzoyl chloride derivatization and liquid chromatography-mass spectrometry. Anal. Chem., 84, 412-419.
66. Stoops, W.W., Hatton, K.W., Lofwall, M.R., Nuzzo, P.A. & Walsh, S.L. (2010) Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies. Psychopharmacology, 212, 193-203.
67. Sun, J.Y., Yang, J.Y., Wang, F., Wang, J.Y., Song, W., Su, G.Y., Dong, Y.X. & Wu, C.F. (2011) Lesions of nucleus accumbens affect morphine-induced release of ascorbic acid and GABA but not of glutamate in rats. Addict. Biol., 16, 540-550.
68. Takmakov, P., Zachek, M.K., Keithley, R.B., Bucher, E.S., McCarty, G.S. & Wightman, R.M. (2010) Characterization of local pH changes in brain using fast-scan cyclic voltammetry with carbon microelectrodes. Anal. Chem., 82, 9892-9900.
69. Tan, K.R., Yvon, C., Turiault, M., Mirzabekov, J.J., Doehner, J., Labouèbe, G., Deisseroth, K., Tye, K.M. & Lüscher, C. (2012) GABA neurons of the VTA drive conditioned place aversion. Neuron, 73, 1173-1183.
70. Thompson, P.I., Joel, S.P., John, L., Wedzicha, J.A., Maclean, M. & Slevin, M.L. (1995) Respiratory depression following morphine and morphine-6-glucuronide in normal subjects. Brit. J. Clin. Pharmaco., 40, 145-152.
71. Vander Weele, C.M., Lovic, V. & Aragona, B.J. (2011) Rapid dopamine signaling in response to a short-acting opiatae, remifentanil. Society for Neuroscience. 41st Annual Meeting. Washington, District of Columbia.
72. Venton, B.J., Michael, D.J. & Wightman, R.M. (2003) Correlation of local changes in extracellular oxygen and pH that accompany dopaminergic terminal activity in the rat caudate-putamen. J. Neurochem., 84, 373-381.
73. Villesen, H.H., Foster, D.J., Upton, R.N., Somogyi, A.A., Martinez, A. & Grant, C. (2006) Cerebral kinetics of oxycodone in conscious sheep. J. Pharm. Sci., 95, 1666-1676.
74. Wightman, R.M., Heien, M.L., Wassum, K.M., Sombers, L.A., Aragona, B.J., Khan, A.S., Ariansen, J.L., Cheer, J.F., Phillips, P.E. & Carelli, R.M. (2007) Dopamine release is heterogeneous within microenvironments of the rat nucleus accumbens. Eur. J. Neurosci., 26, 2046-2054.
75. Will, M., Franzblau, E. & Kelley, A. (2003) Nucleus accumbens μ-opioids regulate intake of a high-fat diet via activation of a distributed brain network. J. Neurosci., 23, 2882-2888.
76. Williams, J.T., Christie, M.J. & Manzoni, O. (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev., 81, 299-343.
77. Willuhn, I., Burgeno, L.M., Everitt, B.J. & Phillips, P.E. (2012) Hierarchical recruitment of phasic dopamine signaling in the striatum during the progression of cocaine use. Proc. Natl. Acad. Sci. USA, 109, 20703-20708.
78. Wydra, K., Golembiowska, K., Zaniewska, M., Kamińska, K., Ferraro, L., Fuxe, K. & Filip, M. (2013) Accumbal and pallidal dopamine, glutamate and GABA overflow during cocaine self-administration and its extinction in rats. Addict. Biol., 18, 307-324.
79. van Zessen, R., Phillips, J.L., Budygin, E.A. & Stuber, G.D. (2012) Activation of VTA GABA neurons disrupts reward consumption. Neuron, 73, 1184-1194.
80. Zhang, Y., Picetti, R., Butelman, E.R., Schlussman, S.D., Ho, A. & Kreek, M.J. (2009) Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice. Neuropsychopharmacology, 34, 912-922.
81. Zhang, Y., Mayer-Blackwell, B., Schlussman, S.D., Randesi, M., Butelman, E.R., Ho, A., Ott, J. & Kreek, M.J. (2014) Extended access oxycodone self-administration and neurotransmitter receptor gene expression in the dorsal striatum of adult C57BL/6 J mice. Psychopharmacology, 231, 1277-1287.